Nuwellis, Inc. (NUWE) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Nuwellis, Inc. (NUWE) stock forecast summary
Our AI ranks Nuwellis, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Nuwellis, Inc. is a small-cap company with a market capitalization of $2M. It ranks number 29 by market capitalization among the 30 Electromedical & Electrotherapeutic Apparatus issuers in our coverage with a current forecast.
For NUWE, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -24.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 3.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, NUWE included.
Follow NUWE freeNUWE price chart and AI forecast
How NUWE ranks among 5171 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Nuwellis, Inc. (NUWE) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Electromedical & Electrotherapeutic Apparatus peers listed below that report each metric.
Financial statement data is not available for this company: its filings are not in a form the pipeline converts, so only market data is shown.
Valuation & Market
| Metric | NUWE | Rank |
|---|---|---|
| Market Cap | $2M | 29/30 |
Profitability & Margins
| Metric | NUWE | Rank |
|---|---|---|
| Gross Margin | 69.7% | 9/27 |
| Operating Margin | -142.9% | 22/28 |
| EBT Margin | -125.6% | 22/28 |
| Tax Rate | 0.0% | – |
Financial Health
| Metric | NUWE | Rank |
|---|---|---|
| Current Ratio | 1.97x | 17/30 |
| Quick Ratio | 1.54x | 16/29 |
| Interest Coverage | -59.7x | 21/30 |
Cash Flow
| Metric | NUWE | Rank |
|---|---|---|
| FCF/Sales | -139.7% | 12/14 |
| CapEx/Sales | 1.4% | 8/14 |
Operational Efficiency
| Metric | NUWE | Rank |
|---|---|---|
| Asset Turnover | 0.99x | 4/19 |
| Receivables Turnover | 5.8x | 13/20 |
| Inventory Turnover | 1.6x | 19/27 |
| Fixed Assets Turnover | 26.0x | 10/20 |
| Days Sales Outstanding | 63 days | 8/20 |
| Days Inventory | 233 days | 9/27 |
| Payables Period | 387 days | 4/24 |
| Cash Conversion Cycle | -92 days | 16/19 |
Dividend & Shareholder Information
| Metric | NUWE | Rank |
|---|---|---|
| Shares Outstanding | 4M | – |
NUWE quarterly financials and insider trading
Nuwellis, Inc. (NUWE) industry peers
Companies classified under the same SEC industry code as Nuwellis, Inc. (Electromedical & Electrotherapeutic Apparatus): 32 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| NUWE Nuwellis, Inc. | ▼ | $2M |
| MDT Medtronic Plc | ▼ | $121.20B |
| ITGR Integer Holdings Corp | ▼ | $4.31B |
| LIVN Livanova Plc | ▼ | $4.27B |
| TMDX Transmedics Group, Inc. | ▲ | $2.65B |
| BLFS Biolife Solutions Inc | ▶ | $1.89B |
| AXGN Axogen, Inc. | ▲ | $1.86B |
| CNMD Conmed Corp | ▼ | $1.40B |
| CBLL Ceribell, Inc. | ▲ | $961M |
| INMD Inmode Ltd. | ▼ | $814M |
| CV Capsovision, Inc | ▶ | $323M |
| ELMD Electromed, Inc. | ▼ | $229M |
| FOCL Edap Tms Sa | ▲ | $153M |
| STXS Stereotaxis, Inc. | ▶ | $105M |
| VANI Vivani Medical, Inc. | ▶ | $104M |
| NRXS Neuraxis, Inc | ▲ | $97M |
| HYPR Hyperfine, Inc. | ▲ | $77M |
| OM Outset Medical, Inc. | ▲ | $77M |
| ECOR Electrocore, Inc. | ▲ | $71M |
| POSC Positron Corp | ▲ | $53M |
| VASO Vaso Corp | ▲ | $51M |
| POCI Precision Optics Corporation, Inc. | ▲ | $48M |
| QTI Qt Imaging Holdings, Inc. | ▶ | $35M |
| ITOC Itonic Holdings Ltd | ▼ | $29M |
| GTHP Guided Therapeutics Inc | ▲ | $18M |
| IRIX Iridex Corp | ▲ | $14M |
| NDRA Endra Life Sciences Inc. | ▶ | $7M |
| ADMT Adm Tronics Unlimited, Inc. | ▶ | $3M |
| NXL Nexalin Technology, Inc. | ▼ | $2M |
| ESMC Escalon Medical Corp | ▲ | $1M |
| HCIL Hongchang International Co., Ltd | ▼ | N/A |
| YBGJ Yubo International Biotech Ltd | ▶ | N/A |
Where NUWE sits on the market map
Nuwellis, Inc. (NUWE) stock news
Loading...
Nuwellis, Inc. (NUWE) stock forecast FAQ
What is the Nuwellis, Inc. (NUWE) stock forecast?
Our AI ranks Nuwellis, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Nuwellis, Inc. stock predictions?
For NUWE, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -24.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 3.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Nuwellis, Inc. forecasts updated?
Nuwellis, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Nuwellis, Inc.'s industry peers?
32 issuers in our coverage, NUWE included, share the SEC industry code Electromedical & Electrotherapeutic Apparatus. The largest are: Medtronic Plc (MDT), Integer Holdings Corp (ITGR), Livanova Plc (LIVN), Transmedics Group, Inc. (TMDX), Biolife Solutions Inc (BLFS), Axogen, Inc. (AXGN).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.